New cholesterol advice: think early

Cholesterol advice in the United States is moving backward in age, not because 30-year-olds suddenly got sicker in 2026, but because artery damage builds the way rust builds in a pipe: slowly, over decades, before symptoms show up. The new American College of Cardiology and American Heart Association guideline was released on March 13, 2026, and it replaces the 2018 cholesterol guideline. (heart.org) Low-density lipoprotein cholesterol is the kind that helps form plaque, which is the fatty buildup that narrows arteries supplying the heart and brain. The guideline says treatment should start earlier to reduce “lifelong risk of prolonged exposure” to those plaque-causing particles. (heart.org) The shift is most visible in adults ages 30 to 79, because that is now the age range for the American Heart Association’s newer PREVENT risk equations, which estimate both 10-year and 30-year cardiovascular risk. The older pooled cohort calculator was built around shorter-term risk and missed many younger adults whose 10-year risk looks low simply because they are young. (heart.org) The new document says doctors can consider cholesterol-lowering treatment in young adults with low-density lipoprotein cholesterol of 160 milligrams per deciliter or higher, or with a strong family history of premature atherosclerotic cardiovascular disease. That is the part that makes age 30 newly relevant: some people are no longer told to wait until 40 for a serious prevention conversation. (heart.org) This did not come out of nowhere. A 2021 JAMA Cardiology study that pooled 18,288 people from four United States cohorts found that cumulative low-density lipoprotein exposure from ages 18 to 60 predicted later coronary heart disease, even after accounting for cholesterol levels in middle age. (jamanetwork.com) In plain English, a person with mildly high cholesterol for 25 years can carry more damage than a person with a worse reading at one doctor visit in midlife. The National Heart, Lung, and Blood Institute said that same research showed adults who kept low-density lipoprotein cholesterol normal in young adulthood and middle age were less likely to develop coronary heart disease. (nih.gov) The guideline does not tell every 30-year-old to start a statin. It says lifestyle comes first, including healthy weight, regular physical activity, tobacco avoidance, and healthy sleep, and then medication enters the picture earlier if numbers stay high or inherited risk is strong. (acc.org) It also brings back treatment goals, not just percentage drops. The guideline says low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol targets should guide therapy, which is a more concrete approach than simply saying “lower is better” and checking again later. (heart.org) Another change is that lipoprotein(a), which is a mostly inherited cholesterol-related particle, should be measured at least once in adulthood. The guideline calls lipoprotein(a) a risk-enhancing factor at 125 nanomoles per liter, or 50 milligrams per deciliter, and says levels at 250 nanomoles per liter, or 100 milligrams per deciliter, are linked to about double the estimated risk. (heart.org) For people who look borderline on paper, the guideline also leans on coronary artery calcium scoring, which is a scan that looks for hardened plaque already sitting in the artery wall. It says that scan can help reclassify risk in men at least 40 and women at least 45, which gives doctors a way to separate “watch this” from “treat this now.” (heart.org) The practical message is that cholesterol is being treated more like blood pressure and less like a one-time lab surprise in middle age. The American College of Cardiology press release says 1 in 4 United States adults has high low-density lipoprotein cholesterol, and the writing committee chair said lower low-density lipoprotein cholesterol “for longer” gives much greater protection against future heart attack and stroke. (acc.org)